US › Healthcare

VivoSim Labs, Inc. (VIVS)

US · Healthcare · Biotechnology

$0.37+9.68%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$40,000

Revenue YoY

+8.1%

Net profit

$-5.8M

Profit YoY

-102.7%

EPS

$-2.21

Net margin

-14,410.0%

Key statistics

Market cap

$1.2M

Forward P/E

0.0

P/B

0.54

Book value

$1.70

EPS (TTM)

$-5.35

52-week high

$5.30

52-week low

$0.31

50-day MA

$0.96

200-day MA

$1.70

Beta

1.40

Shareholding

Insiders

2.70%

Institutions

1.66%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.05%
The Goldman Sachs Group Inc	0.46%
Vanguard Capital Management, LLC	0.44%
BlackRock Inc	0.34%
Vanguard Fiduciary Trust Co	0.20%
Citigroup Inc	0.19%
Tower Research Capital LLC	0.07%
UBS Group AG	0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for VivoSim Labs, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.